Finally, the results of this study must be interpreted with great caution because our patients were all Japanese individuals with AAV, the clinical manifestations of which differ between Japanese and Western populations; for example, more interstitial lung diseases and more positive MPO-ANCA were observed in studies of Japanese AAV patients.[27] Our findings may not apply to AAV patients in Western countries. This evidence concerns the gene MPO and interstitial lung disease.